共 50 条
- [41] Durvalumab for the treatment of PD-L1 non-small cell lung cancer EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
- [45] Concomitant PD-L1 Expression and Driver Oncogenes in Non-small Cell Lung Cancer JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1003 - 1003
- [46] PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations ONCOIMMUNOLOGY, 2016, 5 (05):